(Q50061542)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29432615%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference

30 October 2020

Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29432615%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference

30 October 2020

1 reference

30 October 2020

1 reference

30 October 2020

Jason K Sa

33

0 references

Federico Roncaroli

Federico Roncaroli

32

0 references

Simone P Niclou

Simone P Niclou

27

0 references

Sean Grimmond

Sean Grimmond

51

0 references

Jill S. Barnholtz-Sloan

Jill S Barnholtz-Sloan

4

0 references

Samirkumar Amin

Samirkumar B Amin

2

0 references

Guido Reifenberger

31

Guido Reifenberger

1 reference

PubMed publication ID

24 February 2018

37

Ghazaleh Tabatabai

1 reference

PubMed publication ID

24 February 2018

GLASS Consortium

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29432615%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

publication date

1 June 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29432615%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

18 June 2018

1 reference

30 October 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29432615%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

30 October 2020

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29432615%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29432615%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

page(s)

873-884

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29432615%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 4.0 International

16 March 2020

copyright license

1 reference

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

30 October 2020

cites work

1 reference

12 December 2020

Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging

1 reference

12 December 2020

Molecular structure of double-minute chromosomes bearing amplified copies of the epidermal growth factor receptor gene in gliomas

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

1 reference

12 December 2020

A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.

1 reference

12 December 2020

Microarray analysis of MRI-defined tissue samples in glioblastoma reveals differences in regional expression of therapeutic targets.

1 reference

12 December 2020

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

1 reference

12 December 2020

IDH1 and IDH2 mutations in gliomas

1 reference

12 December 2020

Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility

1 reference

12 December 2020

MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.

1 reference

12 December 2020

Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.

1 reference

12 December 2020

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

1 reference

12 December 2020

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group

1 reference

12 December 2020

International network of cancer genome projects

1 reference

12 December 2020

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

1 reference

12 December 2020

Advances in the treatment of malignant gliomas

1 reference

12 December 2020

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

1 reference

12 December 2020

Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?

1 reference

12 December 2020

Tumour evolution inferred by single-cell sequencing

1 reference

12 December 2020

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

1 reference

12 December 2020

Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.

1 reference

12 December 2020

Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response

1 reference

12 December 2020

IDH mutation impairs histone demethylation and results in a block to cell differentiation

1 reference

12 December 2020

Detection of "oncometabolite" 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma

1 reference

12 December 2020

The Pediatric Cancer Genome Project

1 reference

12 December 2020

Defining the mode of tumour growth by clonal analysis

1 reference

12 December 2020

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

1 reference

12 December 2020

Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas

1 reference

12 December 2020

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

1 reference

12 December 2020

Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group

1 reference

12 December 2020

Standards of care for treatment of recurrent glioblastoma--are we there yet?

1 reference

12 December 2020

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.

1 reference

12 December 2020

A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival

1 reference

12 December 2020

Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.

1 reference

12 December 2020

Tumour heterogeneity in the clinic

1 reference

12 December 2020

Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation.

1 reference

12 December 2020

The somatic genomic landscape of glioblastoma

1 reference

12 December 2020

Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA.

1 reference

12 December 2020

Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma

1 reference

12 December 2020

Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features

1 reference

12 December 2020

EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing

1 reference

12 December 2020

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

1 reference

12 December 2020

International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading

1 reference

12 December 2020

Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma.

1 reference

12 December 2020

Antiangiogenic therapy for high-grade glioma

1 reference

12 December 2020

ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.

1 reference

12 December 2020

Extrachromosomal driver mutations in glioblastoma and low-grade glioma

1 reference

12 December 2020

Deep sequencing of multiple regions of glial tumors reveals spatial heterogeneity for mutations in clinically relevant genes

1 reference

12 December 2020

Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution

1 reference

12 December 2020

Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas.

1 reference

12 December 2020

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas

1 reference

12 December 2020

Mutational landscape and clonal architecture in grade II and III gliomas

1 reference

12 December 2020

From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity.

1 reference

12 December 2020

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

1 reference

12 December 2020

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

1 reference

12 December 2020

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials

1 reference

12 December 2020

Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma.

1 reference

12 December 2020

Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.

1 reference

12 December 2020

DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors

1 reference

12 December 2020

Spatiotemporal Evolution of the Primary Glioblastoma Genome.

1 reference

12 December 2020

Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance

1 reference

12 December 2020

Integrated genomic characterization of IDH1-mutant glioma malignant progression

1 reference

12 December 2020

Insulator dysfunction and oncogene activation in IDH mutant gliomas

1 reference

12 December 2020

Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

1 reference

12 December 2020

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

1 reference

12 December 2020

Histologic classification of gliomas

1 reference

12 December 2020

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.

1 reference

12 December 2020

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

1 reference

12 December 2020

CANCER IMMUNOLOGY. The "cancer immunogram".

1 reference

12 December 2020

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

1 reference

12 December 2020

Longitudinal genomic characterization of brain tumors for identification of therapeutic vulnerabilities

1 reference

12 December 2020

Clonal evolution of glioblastoma under therapy.

1 reference

12 December 2020

Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma

1 reference

12 December 2020

5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients

1 reference

12 December 2020

Single-cell sequencing maps gene expression to mutational phylogenies in PDGF- and EGF-driven gliomas

1 reference

12 December 2020

A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples

1 reference

12 December 2020

Overcoming therapeutic resistance in glioblastoma: the way forward

1 reference

12 December 2020

Longitudinal analysis of treatment-induced genomic alterations in gliomas.

1 reference

12 December 2020

Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity

1 reference

12 December 2020

Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas

1 reference

12 December 2020

Spatiotemporal genomic architecture informs precision oncology in glioblastoma

1 reference

12 December 2020

Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma

1 reference

12 December 2020

Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas

1 reference

12 December 2020

Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors

1 reference

12 December 2020

Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq.

1 reference

12 December 2020

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013.

1 reference

12 December 2020

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

1 reference

12 December 2020

Base resolution maps reveal the importance of 5-hydroxymethylcytosine in a human glioblastoma

1 reference

12 December 2020

Reconstructing the molecular life history of gliomas.

1 reference

12 December 2020

A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence.

1 reference

12 December 2020

Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma

1 reference

12 December 2020

The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space

1 reference

12 December 2020

Identifiers

DOI

10.1093/NEUONC/NOY020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29432615%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29432615%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

PubMed publication ID

29432615

1 reference